Premier Asset Management LLC Gamida Cell Ltd. Transaction History

Premier Asset Management LLC

  • $0
  • Q1 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$2.2 - $4.46 $28,133 - $57,034
-12,788 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.85 - $6.44 $376,807 - $630,295
-97,872 Reduced 88.44%
12,788 $50,000
Q2 2021

Aug 16, 2021
BUY
$5.85 - $8.33 $141,546 - $201,552
24,196 Added 27.98%
110,660 $709,000
Q1 2021

May 12, 2021
BUY
$7.8 - $12.43 $674,419 - $1.07 Million
86,464 New
86,464 $699,000

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Premier Asset Management LLC Portfolio

Follow Premier Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email